Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Stage II-III Non-small Cell Lung Cancer”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Testing effectiveness (Phase 2)Looking for participantsNCT05913089
What this trial is testing

A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07775040
What this trial is testing

Spatially Fractionated Radiotherapy With Tislelizumab and Chemotherapy for Bulky Stage III NSCLC: A Phase II Trial

Who this might be right for
Non-Small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute 43
Large-scale testing (Phase 3)Looking for participantsNCT06284317
What this trial is testing

Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

Who this might be right for
Non Small Cell Lung Cancer
ETOP IBCSG Partners Foundation 290
Large-scale testing (Phase 3)Looking for participantsNCT07251582
What this trial is testing

Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
Hunan Province Tumor Hospital 186
Testing effectiveness (Phase 2)Looking for participantsNCT04302025
What this trial is testing

Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 99
Testing effectiveness (Phase 2)Study completedNCT04776447
What this trial is testing

Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung Cancer+4 more
Fundación GECP 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT04245514
What this trial is testing

Multimodality Treatment in Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung CancerNSCLC
Swiss Cancer Institute 90
Large-scale testing (Phase 3)Looking for participantsNCT04316364
What this trial is testing

A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 537
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Large-scale testing (Phase 3)Study completedNCT00003901
What this trial is testing

Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 1,310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06585644
What this trial is testing

A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 44
Testing effectiveness (Phase 2)UnknownNCT04202809
What this trial is testing

Phase-II Trial of Induction Chemotherapy and Chemoradiotherapy Plus/Minus Durvalumab and Consolidation Immunotherapy in Patients With Resectable Stage III NSCLC.

Who this might be right for
NSCLC, Stage III
University Hospital, Essen 90
Testing effectiveness (Phase 2)Looking for participantsNCT05742607
What this trial is testing

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

Who this might be right for
Non Small Cell Lung Cancer
Innate Pharma 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07402070
What this trial is testing

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage II-III Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 10
Early research (Phase 1)UnknownNCT00006212
What this trial is testing

Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Center for Molecular Medicine
Testing effectiveness (Phase 2)Study completedNCT00463515
What this trial is testing

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

Who this might be right for
Non-Small-Cell-Lung Cancer
University Hospital, Antwerp 77
Large-scale testing (Phase 3)Looking for participantsNCT07642024
What this trial is testing

BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT04158440
What this trial is testing

Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC

Who this might be right for
Stage II-III Non-small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 501
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)UnknownNCT04304248
What this trial is testing

Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Hao Long 30
Next Page